Theme: “Exploring Novel Approaches in Virology”

Virology 2016

Renowned Speakers

Virology 2016

Conference Series LLC invites all the participants from all over the world to attend “8th World Congress on Virology” during November 28-30, 2016 at San Antonio, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Target Audience:

  • Virology Students, Scientists
  • Virology Researchers
  • Virology Faculty
  • Medical Colleges
  • Virology Associations and Societies
  • Research Labs
  • Manufacturing Medical Devices Companies

Scope and Importance:

Virology-2016 will give a new look to study of viruses.Virology is often considered a part of microbiology or of pathology. Viruses and viral diseases have been at the centers of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. Virology 2016 addresses and discuss on the recent advancements and technologies being used and developed for the research on viruses.Our virology conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders.

The Global microbiology market is growing due to increase in prevalence of pathogenic diseases, growth in discovery of mutating and adapting bacterium, and the growing need for speedy microbiological testing methods. The report Global Microbiology Market forecast for 2018’ analyzes the market by segments such as instruments and reagents. These two segments experienced a positive growth till 2013, with a market value of $3.55 billion, comprising of $2.99 billion for reagents and $0.55 billion for instruments. It is expected to grow at a CAGR of 6.2%.The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018. The report “North American Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents.

Summary:Virology-2016 welcomes attendees, presenters, and exhibitors from all over the world to San Antonio. We are delighted to invite you all to attend and register for the 8th World Congress on Virology which is going to be held during November 28-30 in San Antonio, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Virology-2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Virology-2016 organizing committee are looking forward to meet you in San Antonio, USA.

For more details please visit- http://virology.omicsgroup.com/

Importance & Scope:

           Virology is the study of viruses – submicroscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. Virology is often considered a part of microbiology or of pathology. Viruses and viral diseases have been at the centers of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. Our virology conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders.

Why San Antonio,USA?

San Antonio officially the City of San Antonio, is the seventh most populated city in the United States of America and the second most populated city in the state of Texas, with a population of 1,409,019. Greater San Antonio, the metropolitan area has a population of over 2.27 million based on the 2013 US Census estimate, making it the 25th-largest metropolitan area in the United States and third-largest in the state of Texas. The city is located in the American Southwest, the south–central part of Texas, and the southwestern corner of an urban region known as the Texas Triangle. The Alamo Mission in San Antonio ("the Alamo"), located in Downtown, is Texas' top tourist attraction. Because of the mission, San Antonio is often called the "Alamo City". The River Walk, which meanders through the Downtown area, is the city's second-most-visited attraction.

Conference Highlights:

  • General Virology and Basic Science
  • Clinical and Neuro Virology
  • Respiratory and Emerging/Re-emerging Viruses
  • Agriculture and Plant Virology
  • Therapeutic Approaches and Targets for Viral Infections
  • Veterinary Virology
  • Viral Immunology
  • Viral Hepatitis
  • HIV and Other Retroviral Diseases Affecting Afro-Asian Continents
  • Organ specific Cancer and Tumor virology
  • Regulatory and Economical Aspects in Virology
  • Recent Advances in Drug Discovery
  • Current Focus in Virology Research

Why to attend???

It will provide exposure to the on-going researches in Virology and related science. It will also provide insight to the novel inventions and techniques. It is very beneficial for the students and fellowship owners because it provides knowledge in the field. It also gives opportunities to the companies to showcase their products and have face to face meetings with scientists increasing their business opportunities.It also gives companies to know about their market competitors.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://virology.omicsgroup.com/sponsors.php   

Top Societies and Association around the World

  • Center for Emerging Viral Infections Research
  • Hunter Medical Research Institute
  • Center for Global Research and Intervention in Infectious Diseases
  • Infectious and Immunologic Diseases Research Center
  • Global virus network
  • HIV Medicine Association
  • International AIDS Society
  • Canadian Society for International Health 

Top Societies and Associations in USA

  • Infectious Diseases  Society of America
  • American Society for Virology
  • Pan American Society for Clinical Virology
  • International Society for Antiviral Research

Statistical Analysis of Associations

Figure 1: Statistical Analysis

Source: reference 1

Target Audience:

  • Scientists
  • Research Scholars
  • Associate Professors
  •  Professors
  • Lecturers
  • M.Sc Students
  • Pharmaceutical Industries
  • Healthcare Industries
  • Directors of Associations and Societies

Target Audience:

Industry        40%

Academia      60%

Others           10%

Figure 2: Target Audience

Top Universities in USA:

  • Rice University
  • Texas A&M University
  • LeTourneau University
  • University of Texas at Dallas
  • Southwestern University
  • Texas Tech University

Figure 3: Top Universities in USA

Source-reference 2

Companies Associated with Virology

Figure 4:  Companies Associated with Virology

Source-reference 3

Research Institutes and Labs Associated with Virology

Figure 5: Research institutes and labs Associated with Virology

Source-reference 4

Statistics of Scientists working on Virology:

Figure 6: No. of Scientists working on virology.

References:

  1.  http://www.virology.net/garryfavweborg.html
  2.  http://www.bestcolleges.com/features/best-colleges-in-texas/
  3.  http://www.virology.net/garryfavwebvirlabs.html
  4.  http://www.virology.net/garryfavwebvirlabs.html

 

 

Virology 2016 welcomes attendees, presenters, and exhibitors from all over the world to San Antonio, USA. We are delighted to invite you all to attend and register for the “8th World Congress on Virology (Virology 2016)” which is going to be held during November 28-30 , 2016 at San Antonio, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Virology-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Virology 2016 organizing committee look forward to meet you at San Antonio, USA.

Track 1: General Virology and Basic Science

The Americas commanded the most sizably voluminous share 42% of the Ecumenical Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

A viral contamination is one of the real reasons for human and animal illness. Virus genomes are small and they are unimaginably different and subject to quick hereditary change. Virus have their own particular manners of transmission. The portability of animals builds the systems of viral transmittance that are advanced, while plants stay stable and in this way infections should depend on ecological components to be transmitted between hosts.

Relevant Conferences:

8th World Congress on Virology November 28-30, 2016 San Antonio, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 10th Asia-Pacific Medical Virology conference,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany;6th European Congress of Virology,Oct 19-22,2016 Germany; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists

Track 2: Clinical and Neuro Virology,

Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019", states that the global clinical trial management systems market, which was worth US$844 million in 2013, will grow at a CAGR of 14% between 2013 and 2019 to acquire net worth of an estimated US$1,848.5 million by 2019.

Vector-borne diseases are contamination's transmitted by the bite of tainted arthropod species, for example, mosquitoes, ticks, sandflies, blackflies,etc. A blood-borne disease is one that can be spread through defilement by blood and other body liquids. RNA silencing controls gene expression to direct improvement, genome security and tension instigated responses. In plants, RNA silencing is likewise perceived as a noteworthy immune system targeted against plant viruses.

Relevant Conferences:

8th World Virology Meeting November 28-30, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology          

Track 3: Respiratory and Emerging/Re-emerging Viruses

As indicated by the U.S. Community for Disease Control and Prevention (CDC), Respiratory syncytial infection (RSV) is the basic reason for bronchiolitis or pneumonia in the youngsters under one year of age in the United States. Every year 75,000 to 125,000 kids are hospitalized because of RSV diseases.

An alphavirus has a place with the gathering IV Togaviridae group of infections according to the arrangement of grouping considering viral genome association displayed by David Baltimore. Filoviruses fit in with an virus family called Filoviridae and can bring about serious hemorrhagic fever in people and nonhuman primates. Picornaviruses are non-wrapped, positive-stranded RNA infections with an icosahedral capsid. West Nile infection is a mosquito-borne zoonotic arbovirus having a place with the genus Flavivirus in the family Flaviviridae.

Relevant Conferences:

2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Infectious Diseases Congress August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control November 28-29, 2016 Valencia, Spain; 4th International Bacteriology and Infectious Diseases Congress May 16-18 2016, Texas,USA; 5th Influenza Research & Development 2016,  USA;  Influenza Vaccines for the World October 6-9 October 2015, Portugal.World Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology

Track 4: Agriculture and Plant Virology

The agricultural inoculants market, in terms of value is anticipated to reach $398.56 million by 2019, at a CAGR of around 9.5% from 2014.

The study of disease transmission of plant virus diseases concerns the patterned improvement of virus diseases within plant population in time and space. Tobacco mosaic infection (TMV) is a positive-sense single stranded RNA virus that taints an extensive variety of plants, particularly tobacco and different individuals from the family Solanaceae. Mycology is the branch of science which manages the investigation of fungi, including their hereditary and biochemical properties, their scientific classification and their utilization to people as a source for tinder, drug, wine and entheogens, and also their threats, for example, harming or disease.

Relevant Conferences:

4th International Plant Genomics Conference, July 14-15, 2016 Brisbane, Australia; Global Summit on Plant Science, October 06-08, 2016 London, UK; 5th International Conference on Agriculture and Horticulture, June 27-29, 2016 Cape Town, South Africa; International Plant Physiology Conference, June 9-11, 2016 Dallas,USA; XIIIth International Plant Virus Epidemiology Symposium,June 6-10,2016 ,France; Australasian Plant Pathology Conference,September 14-16,2016 Fremantle, Western Australia; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

Track 5: Therapeutic Approaches and Targets for Viral Infections

The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

DNA inoculation is a novel strategy used to proficiently brace humoral and cell safe reactions to protein antigens. Viral antibodies contain either inactivated viruses or choked viruses .Inactive viral antibodies contain a virus, which have lost their capacity to replicate and in order for it to bring about a response it contains more antigen than live vaccinations. Allergy immunotherapy is a clinically archived effective treatment, which might impressively lessen the patient's allergic symptoms and the requirement for conventional, side effect soothing solution. Antiviral medications are a class of medicine used especially to treat viral contaminations.   

Relevant Conferences:

3rd Global Microbiologists Annual Meeting August 15-17, 2016 Portland, USA;2nd World Congress On Beneficial Microbes ,September 23-25, 2016 Phoenix, USA; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada;International Microbial Physiology And Genomics Conference October 20-22, 2016 Rome, Italy; Microscopy Congress, 30th November - 1st December 2015, London, UK; New Approaches and Concepts in Clinical Microbiology,October 11 - 14, 2015, Heidelberg, Germany;19th International Conference on Recent Advances in Biomedical Science, January 9th, 2016, Kuala Lumpur, Malaysia; 3rd International Conference on Advances in Environment, Biomedical Sciences, January 12-13, 2016, Abu Dhabi,UAE. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists

Track 6: Veterinary Virology

The global animal healthcare market was esteemed at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to achieve an expected estimation of USD 41,929.1 million in 2019.

Veterinary virology is the investigation of viruses in animals. It is a critical branch of veterinary medicine. A emerging virus is a term connected to a new found virus, one that is increasing in occurrence or with the possibility to increment in rate. Zoonotic diseases /contamination's are those which can be actually transmissible from vertebrate animals to humans. Prion disease represents to a group of conditions that influence the nervous system in humans and animals.

Relevant Conferences:

8th World Virology Meeting November 28-30, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists

Track 7: Viral Immunology

The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.

Cell signaling is a part of an intricate arrangement of communication that directs basic cellular exercises and facilitates cell activities. A Neutralizing antibody is a counter acting agent which defends a cell from an antigen or infectious body by repressing or killing any effect it has naturally. Cell-mediated immunity is a resistant reaction that does not include antibodies, but instead includes the initiation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the arrival of different cytokines in response of an antigen.

Relevant Conferences:

2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Infectious Diseases Congress August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control November 28-29, 2016 Valencia, Spain; 4th International Bacteriology and Infectious Diseases Congress May 16-18 2016, Texas,USA; 5th Influenza Research & Development 2016,  USA;  Influenza Vaccines for the World October 6-9 October 2015, Portugal.World Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology

Track 8: Viral Hepatitis

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a therapeutic condition characterized by the inflammation of the liver and described by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an extraordinary overwhelming disease of the liver created by the hepatitis A virus. Hepatitis B is an infectious disease brought about by the hepatitis B infection (HBV) which influences the liver. It can bring about both serious and chronic infections. HCV is spread fundamentally by blood-to-blood contact associated with intravenous medication use, insufficiently cleaned therapeutic gear, and transfusions.

Relevant Conferences:

3rd World Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 2nd International Conference on Hepatology, May 09-11, 2016, USA; 5th  International Conference and Exhibition on Pathology, May 09-11, 2016,USA ; World Pathology Congress, June 16-18, 2016, Spain; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Latin and Ibero American Congress of Paediatric Gastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France ; 12th Congress of E-AHPBA, May 23-26, 2017, Mainz, Germany; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists

Track 9: HIV and Other Retroviral Diseases Affecting Afro-Asian Continents

The global HIV/AIDS market, including branded products and generics, was esteemed at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 estimate period to reach $14.1 billion in 2016.

The human immunodeficiency virus is a lentivirus that causes HIV disease and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are exploration done to have improved approach, recognize, or treat HIV/AIDS. Clinical trials are the quickest approach to figure out whether new restorative ways to deal with HIV/AIDS are safe and effective in individuals.

Relevant Conferences:

8th World Virology Meeting November 28-30, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Florida, USA; 2nd World Infectious Diseases Congress August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. American Society for Microbiology , Society for General Microbiology, Society for Applied Microbiology, Canadian Society of Microbiologists

Track-10: Organ specific Cancer and Tumor virology

The global Cancer/Tumor Profiling Market was esteemed at $13.30 billion in 2012. At the end of 2013, the market is assessed to be $14.99 billion and is poised to reach around $35 billion by 2018, developing at a CAGR of 18.50% from 2013 to 2018.

Viral gastroenteritis is an inflammation of the stomach and intestines created by one of any number of viruses. It is otherwise called as the stomach flu. Hepatocellular carcinoma is the most well-known sort of liver cancer. Most examples of HCC are secondary to either a viral hepatitis contamination or cirrhosis. Simian infection 40, a polyomavirus that is found in both monkeys and humans. It was named for the effect it made on contaminated green monkey cells, which showed a strange number of vacuoles.

Relevant Conferences:

2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Infectious Diseases & Diagnostic Microbiology Conference , October3-5, 2016; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

Track 11: Regulatory and Economical Aspects in Virology

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%.

Major point driving growth of vaccine technology market incorporate rising pervasiveness of infections, increasing government activities for growing immunization over the globe, expanding organization interests in immunization improvement, and rising activities by non-government associations for immunizations. Clinical trials are research studies that investigate whether a medicinal methodology, treatment, or device is safe and effective for humans.

Relevant Conferences:

2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Infectious Diseases & Diagnostic Microbiology Conference , October3-5, 2016; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

Track 12: Recent Advances in Drug Discovery

The worldwide business sector for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% somewhere around 2012 and 2017. Another report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.

Drug-drug interactions occur when a drug interacts, or interferes, with another drug modify the way one or both of the drugs act in the body, or cause unexpected side effects. The drugs involved can be prescription medications, over-the-counter medicines and even vitamins and natural products.

Relevant Conferences:

2nd International Conference and Expo on Drug Discovery & Designing, November 08-09, 2016 Istanbul, Turkey; Structure Based Drug Design Conference, February 21–24, 2016, USA; 8th International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery Systems March 07-09, 2016, Spain; 11th Annual Fragment-Based Drug Discovery, April 20-21, 2016, USA; Drug Discovery and Therapy World Congress May 11-14, 2016, USA; 4th Annual conferences on European Pharma Congress June 13-15, 2016, Germany; 9th World Drug Delivery Summit June 30-July 02, 2016, USA; 7th International conference and exhibition on Pharmacovigilance and Clinical Trials September 19-21, 2016, Austria; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016, Spain. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

Track 13: Current Focus in Virology Research

The global stem cell therapy market over the forecast period of 2015 to 2020. The business is ready to grow at a CAGR of 39.5% from 2015 to 2020, to achieve $330million by 2020.

Stem cell therapy is the utilization of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem cell therapy, but some therapies derived from umbilical cord blood are also in use. Clinical or medical virology is a branch of medicine which consists in isolating and/or in characterizing one or several viruses responsible for some human pathologies by various different immediate or circuitous systems.

Relevant Conferences:

5th International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; 7th Annual Conference on Stem Cell and Regenerative Medicine, Aug 4-6, 2016, Frankfurt, Germany; 10th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016,  Portland, Oregon; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016 , Colorado, USA; Phacilitate Cell & Gene Therapy World, January 25-27, Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, 1-3 February 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016 Colorado, USA. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

 

 

Virology-2015

5th World Congress on Virology conference, hosted by the Conference Series LLC was held during December 07-09, 2015 Atlanta, USA at Hilton Atlanta Airport Hotel, Atlanta, USA with the theme “Anti-Viral Immunity and Countermeasures to Control Disease Pathogenesis”. Benevolent response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the Scientists, Doctors, Professors, Virology Lecturers, Pharmaceutical Industries, Biotech Industries, Researchers and Students from the fields Virology -2015, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • General Virology and Basic Science
  • Clinical and Neuro Virology
  • Respiratory and Emerging/Re-emerging Viruses
  • Agriculture and Plant Virology
  • Therapeutic Approaches and Targets for Viral Infections
  • Veterinary Virology
  • Viral Immunology
  • Viral Hepatitis
  • HIV and Other Retroviral Diseases Affecting Afro-Asian Continents
  • Organ specific Cancer and Tumor virology
  • Regulatory and Economical Aspects in Virology
  • Recent Advances in Drug Discovery
  • Current Focus in Virology Research

The conference was initiated with opening remarks by Dr. Sita Awasthi followed by Keynote lecture and plenary lectures byDr. Dharam Ablashi, HHV-6 Foundation,KHG fiteBac® Technology,USA, USA, Dr. Ting-Chao Chou, PD Science LLC,USA,Dr. Ronald Moss, Ansun Biopharma,USA,Dr. Shahana Choudhury, Meharry Medical College,USA.

 


Past Reports  Gallery  

Virology-2014

The 4th World Congress on Virology, hosted by the Conference Series LLC was held during October 06-08, 2014 at Hilton San Antonio Airport Hotel, San Antonio, USA with the theme “Anti-Viral Immunity and Counter measures to Control Disease Pathogenesis". Benevolent response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from the scientists, engineers, researchers, students and leaders from the fields of Virology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • General viral science
  • Viral Breakout: Preventions and Measures
  • Human Viral Diseases Affecting Afro-Asian Continents
  • Organ Specific Cancers and Tumours Virology
  • Respiratory and Vector Borne Diseases
  • Therapeutic Approaches and Targets for Viral Infections
  • Viral Hepatitis and Viral Immunology
  • Neurological Infections Associated with Viruses
  • Agriculture and Plant Virology
  • Animal Virus and Bacteriophages
  • Recent Advances in Drug Discovery
  • Current Focus in Virology Research

The conference was initiated with opening remarks by Dr. Sita Awasthi followed by Keynote lecture and plenary lectures byDr.John Edwar Collony, Institute of Molecular and Cellular Biology, USA, Dr.Neal S Rote, Case Western Reserve University, USA,Dr. James Mahony, Mc Master Unviersity, Canada.


Past Reports  Gallery  

Virology-2013

The 3rd World Congress on Virology took place in Baltimore, USA on November 20-22, 2013.The conference was titled: “Exploring Novel Approaches in Virology” and hosted by the Conference Series LLC. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals, Organizing Committee Members, scientists, researchers, clinical experts and leaders from the field of Virology.

The conference was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • HIV Vaccines
  • Therapeutic Approaches and Targets for Viral Infections
  • Human Viral Diseases Affecting Afro-Asian Continents
  • HIV and Other Retroviruses
  • Respiratory Viral Infections
  • Viral Hepatitis
  • Viral Immunology
  • Agriculture and Plant Virology
  • Recent Advances in Drug Discovery

The conference paved its way by the introductory speeches from Honourable guests and members of the Keynote forum such as Dr. Marc H.V. Van Regenmortel, University of Strasbourg, France, Dr. Ruth M. Ruprecht, Texas Biomedical Research Institute, USA, Dr. Jean-Marie Andrieu, University of Paris-Descartes, France,Dr. Hiroshi Ohrui, Yokohama College of Pharmacy, Japan.


Past Reports  Gallery  

Virology -2012

The 2nd World Conference on Virology, hosted by the Conference Series LLC was held during August 20-22, 2012 at Embassy Suites, Las Vegas, USA. Generous response and active participation was received from the Organizing Committee & Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from pharma, government organizations and students who made this conference as one of most successful and productive events in 2012 from OMICS International.


The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

  • HIV Research
  • Agriculture Virology
  • Epidemic studies
  • Animal Virology
  • Influenza Viruses
  • Drug discovery program
  • Hepatitis Research
  • Anti Viral and Retro-viral drugs and therapy
  • Tumor Virology
  • Anti Viral Vaccine development

The conference was initiated with opening remarks by Dr. Pawel Ciborowski followed by Keynote lecture by Dr. N. J. Krogan University of California. Keynote forum included Fatah Kashanchi, George Mason University, USA; Pooja Jain, Drexel University College of Medicine, USA; Ralph Tripp, University of Georgia, USA.


Past Reports  Gallery  

Key Topics

  • Advances in HIV Diagnosis
  • Advances in HIV Medications
  • Advances in HIV Tests
  • Advances in HIV Treatment
  • Advances in Preventive Transmitted Disease
  • AIDS
  • Antiretroviral Therapy
  • Antiretroviral Treatment
  • Antiretrovirals
  • Clinical Virology
  • Coronaviruses
  • Current Focus in Virology Research
  • Drug Resistance of HIV
  • Fifth Disease
  • Gallbladder tuberculosis
  • Hepatitis Virology
  • Highly Active Antiretroviral Therapy
  • HIV Status
  • HIV Super Infection
  • HIV Vaccines
  • HIV Virology
  • Influenza virus
  • Innovative HIV drugs
  • Modern Virology
  • Neuro Virology
  • Plant Virology
  • Retrovirology
  • Risk Analysis: HIV
  • Risk Behaviours of HIV/AIDS
  • Structural Virology
  • Veterinary Virology
  • Viral Hepatitis
  • Viral Infection during Chemotherapy
  • Viral Infection in Brain
  • Viral Infection in Pregnancy
  • Viral Infection in Throat
  • Viral Infection Transmission
  • Viral Infection Treatment drugs
  • Viral Infection Treatment for Babies
  • Viral Infectious Diseases
  • Viral Vaccines
  • Viral Vectors
  • Virology and Immunology
  • Virology Methods
  • Virology Techniques

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 28-30, 2016(10 Plenary Forums-1 Event)
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
virology@conferenceseries.net
Sponsors / Exhibiting / Advertising.
virology@conferenceseries.net
General Queries.
virology@conferenceseries.net

View Proceedings of Previous Conferences

Virology-2015
Virology-2014
Virology-2013
Virology-2012
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.